Clinical Trial Update: A Study of LY573636-sodium in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of LY573636-sodium in metastatic breast cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LY573636-sodium

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-17